X4 Pharmaceuticals (XFOR) PT Lowered to $10 at Stifel
Tweet
Share
E-mailGet Alerts XFOR Hot Sheet
Price: $3.50 +2.94%
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
13 Buy, 1 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Stifel analyst Stephen Willey lowered the price target on X4 Pharmaceuticals (NASDAQ: XFOR) to $10.00 (from $18.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Oracle (ORCL) PT Lowered to $200 at Stifel, Buy Rating Maintained
- Accenture plc (ACN) Reiterated at Buy by Stifel as In-Line Q4 Results Expected
- Clear Secure Inc (YOU) PT Lowered to $45 at DA Davidson
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
StifelSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
